AQUINOX PHARMACEUTICALS, INC 4
4 · AQUINOX PHARMACEUTICALS, INC · Filed Mar 14, 2014
Insider Transaction Report
Form 4
Main David
DirectorPresident and CEO
Transactions
- Disposition to Issuer
Common Exchangeable Shares
2014-03-12$11.00/sh−9,459$104,049→ 0 total→ Common Stock (9,459 underlying) - Disposition to Issuer
Common Special Voting Stock
2014-03-12$11.00/sh−9,459$104,049→ 71,530 total - Conversion
Common Stock
2014-03-12+71,530→ 71,530 total - Conversion
Common Exchangeable Shares
2014-03-12−71,530→ 0 total→ Common Stock (71,530 underlying) - Conversion
Common Special Voting Stock
2014-03-12−71,530→ 0 total
Footnotes (2)
- [F1]Each share of the issuer's Common, Series A-1, Series A-2, Series B-1, Series B-2 and Series C Special Voting Stock was redeemed upon the closing of the issuer's initial public offering for $0.0000192 per share.
- [F2]The Common Exchangeable Shares of Aquinox Pharmaceuticals Inc., a corporation under the Canadian Business Corporations Act ("AQXP Canada"), were exchanged for Common Stock of the issuer on a 1-to-1 basis upon the closing of the issuer's initial public offering, and have no expiration date.